Barclays’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9
| Closed | – | – | 4947 |
|
|
2022
Q2 | $0 | Sell |
9
-282
| -97% | – | ﹤0.01% | 5076 |
|
|
2022
Q1 | $4K | Sell |
291
-1,886
| -87% | -$25.9K | ﹤0.01% | 4625 |
|
|
2021
Q4 | $34K | Buy |
2,177
+1,444
| +197% | +$22.6K | ﹤0.01% | 3064 |
|
|
2021
Q3 | $17K | Buy |
733
+501
| +216% | +$11.6K | ﹤0.01% | 3668 |
|
|
2021
Q2 | $8K | Sell |
232
-1,272
| -85% | -$43.9K | ﹤0.01% | 3920 |
|
|
2021
Q1 | $72K | Buy |
1,504
+923
| +159% | +$44.2K | ﹤0.01% | 3458 |
|
|
2020
Q4 | $28K | Sell |
581
-244
| -30% | -$11.8K | ﹤0.01% | 3333 |
|
|
2020
Q3 | $29K | Sell |
825
-163
| -16% | -$5.73K | ﹤0.01% | 3442 |
|
|
2020
Q2 | $68K | Buy |
988
+985
| +32,833% | +$67.8K | ﹤0.01% | 3286 |
|
|
2020
Q1 | $0 | Sell |
3
-15
| -83% | – | ﹤0.01% | 4024 |
|
|
2019
Q4 | $0 | Buy |
18
+11
| +157% | – | ﹤0.01% | 4371 |
|
|
2019
Q3 | $0 | Sell |
7
-201
| -97% | – | ﹤0.01% | 4536 |
|
|
2019
Q2 | $2K | Sell |
208
-1,148
| -85% | -$11K | ﹤0.01% | 4142 |
|
|
2019
Q1 | $18K | Buy |
1,356
+255
| +23% | +$3.39K | ﹤0.01% | 3935 |
|
|
2018
Q4 | $9K | Buy |
1,101
+321
| +41% | +$2.62K | ﹤0.01% | 3585 |
|
|
2018
Q3 | $18K | Buy |
780
+679
| +672% | +$15.7K | ﹤0.01% | 3942 |
|
|
2018
Q2 | $5K | Sell |
101
-246
| -71% | -$12.2K | ﹤0.01% | 4007 |
|
|
2018
Q1 | $17K | Buy |
347
+108
| +45% | +$5.29K | ﹤0.01% | 3873 |
|
|
2017
Q4 | $11K | Buy |
239
+119
| +99% | +$5.48K | ﹤0.01% | 3817 |
|
|
2017
Q3 | $7K | Buy |
120
+16
| +15% | +$933 | ﹤0.01% | 3561 |
|
|
2017
Q2 | $7K | Buy |
104
+81
| +352% | +$5.45K | ﹤0.01% | 3501 |
|
|
2017
Q1 | $2K | Sell |
23
-385
| -94% | -$33.5K | ﹤0.01% | 3813 |
|
|
2016
Q4 | $61K | Buy |
+408
| New | +$61K | ﹤0.01% | 2767 |
|